#MRNA

World Health Organization (WHO)

WHO

Here are three main approaches to designing a #COVID19 vaccine: the whole-microbe approach the subunit approach the genetic approach (nucleic acid vaccine)Learn more http://bit.ly/3caqsDW The whole-microbe approach uses a whole

Andy Slavitt @ 🏡🇺🇸

ASlavitt

COVID Update January 3: Tonight a thread I’ve been working on for a week. The best we know about the impact of the South African strain. And the impact on

The Economist

TheEconomist

The first fully-tested covid-19 vaccine has been authorised for use in Britain. How did the country's regulator approve the Pfizer-BioNTech jab so quickly? A bumper thread (1/10) https://econ.st/36v2q3l Britain's

VKJudit

VKJudit

It's getting hard to keep up with all the vaccine-related news, so I tried summarizing key developments (with a focus on European supplies) from just the past week: 1, Very

Dr. Tom Frieden

DrTomFrieden

Covid Epi Weekly January 29: To Arms, to Arms!Let’s focus:Get doses out of freezers and into arms ASAPDenominators: What % of nursing home residents and staff have been vaccinated?Improve equity.

Jessica Lu, MD

JessLuMD

This month, I have been working in Shiprock, New Mexico on the Navajo reservation. I could spend years absorbing the grace and beauty of the land and its people, and

Abdu Sharkawy

SharkawyMD

Plenty of angst now re: vaccine shortages, "scariant" variants, what awaits in this winter of relative discontent & beyond. Let's unpack this to maintain some hope for the future. There

Jennifer Depew, RD

deNutrients

Endocannabinoid system has role in vascular health & regulation of inflammation - background info: excess inflammation causes breakdown of the cell membranes to release stored endocannabinoids.this article important to consider

Eric Feigl-Ding

DrEricDing

FANTASTIC NURSING HOME NEWS—Eli Lily’s monoclonal antibody drug can lower the risk symptomatic #COVID19 by 80% when used preventively among nursing home residents. Cuts risks overall by 57% among both

Emilia C Skirmuntt 🦇🧬🦠

ESkirmuntt

Let’s talk about vaccines and dosing again (another thread;) )There is a lot of talk at the moment about dosing and delays. First, it was the UK who decided to

Manzoor

Mizpodcast

رشتو١واكسن كروناى فايزر و نابارورى!فايزر كه يكى از غولهاى صنعت واكسن سازى است به همراه ٣ شركت ديگر بيش از ٪٨٠ درصد سهم بازار را در اخ

Greg

greg_scott84

VACCINES & POPULATION 1) How could the infrastructure rollout for a global Covid vaccine distribution happen so quickly? Is it possible to have this all set up in a few

Mark Toshner

mark_toshner

Quick tweetorial on why the design of the different vaccine studies is important. I'm also going to talk about how reporting has coloured the debate. My disclosures- Minor investigator on

Nick

NStocks96

Here's a thread looking at some stocks as promised. Lets start this new year the right way! $NFLX daily resistance sitting above 550, weekly r around 570. Once 575 turns

Eric Topol

EricTopol

If you want to know about #SARSCoV2 as it started and where it is going, you talk to @edwardcholmes, a leading evolutionary virologist @Sydney_Unihttps://www.medscape.com/viewarticle/943251 @Medscape video and transcripta /1

Dr Sumaiya Shaikh

Neurophysik

COVAXIN Efficacy: A thread...n0 Q1: Is there a method to hypothesise the efficacy of COVAXIN when no data has been released?Q2: How is this efficacy enhanced & measured? Q3: Why

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.